Search by Drug Name or NDC

    NDC 00703-5653-01 Toposar 20 mg/mL Details

    Toposar 20 mg/mL

    Toposar is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is ETOPOSIDE.

    Product Information

    NDC 00703-5653
    Product ID 0703-5653_d51ca63b-e4ab-43d3-ae5b-7324f547fbc1
    Associated GPIs 21500010002025
    GCN Sequence Number 008841
    GCN Sequence Number Description etoposide VIAL 20 MG/ML INTRAVEN
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 07481
    HICL Sequence Number 003930
    HICL Sequence Number Description ETOPOSIDE
    Brand/Generic Generic
    Proprietary Name Toposar
    Proprietary Name Suffix n/a
    Non-Proprietary Name Etoposide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION, CONCENTRATE
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name ETOPOSIDE
    Labeler Name Teva Parenteral Medicines, Inc.
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074529
    Listing Certified Through 2022-12-31

    Package

    NDC 00703-5653-01 (00703565301)

    NDC Package Code 0703-5653-01
    Billing NDC 00703565301
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5653-01) / 5 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 1996-08-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL c9080cf5-4fc3-4cf9-a241-6e40a6fddc75 Details

    Revised: 4/2017